E-Pilo-1 and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with E-Pilo-1 (epinephrine / pilocarpine ophthalmic).
Pilocarpine Ophthalmic High Blood Pressure (Hypertension)
Moderate Potential Hazard, Low plausibility
miotics - systemic vagotonic effects
Topically applied cholinergic agents are systemically absorbed, with the potential for producing rare but clinically significant systemic effects, including urinary incontinence, tightness of the bladder, increased gastric contractility and acid secretion, bradycardia, severe hypotension, bronchospasm, seizures, and coma. Increases in blood pressure may occur rarely due to a nicotinic effect on sympathetic ganglia. Therapy with ophthalmic cholinergic agents, particularly the long-acting cholinesterase inhibitors (e.g., demecarium and echothiophate), should be administered cautiously in patients with corneal abrasion (which may increase drug penetration), bronchospastic diseases, spastic gastrointestinal disturbances, urinary tract obstruction, peptic ulcer, pronounced bradycardia and hypotension, vascular hypertension, acute cardiac failure, recent myocardial infarction, epilepsy, parkinsonism, and other conditions that may respond adversely to vagotonic effects. The usual precautions should be followed to minimize the risk of systemic toxicity, including digital compression of the nasolacrimal ducts (1 to 2 minutes) following instillation to limit drainage into the nasal chamber, where extensive absorption may occur, and washing hands after use to prevent skin absorption. Excessive cholinergic effects may be reversed with parenterally administered atropine.
Switch to professional interaction data
E-Pilo-1 drug interactions
There are 149 drug interactions with E-Pilo-1 (epinephrine / pilocarpine ophthalmic).
E-Pilo-1 disease interactions
There are 9 disease interactions with E-Pilo-1 (epinephrine / pilocarpine ophthalmic) which include:
- retinal detachment
- uveitis
- aphakia
- cardiovascular
- narrow angles
- cataracts
- systemic vagotonic effects
- BPH
- diabetes
More about E-Pilo-1 (epinephrine / pilocarpine ophthalmic)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Alphagan P
Alphagan P is used to treat glaucoma or ocular hypertension (high pressure inside the eye). Learn ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Betagan
Betagan is used for glaucoma, open angle, intraocular hypertension
Betimol
Betimol is used for glaucoma, open angle, intraocular hypertension
Betoptic S
Betoptic S is used for glaucoma, open angle, intraocular hypertension
Combigan
Combigan (brimonidine and timolol) is used to treat glaucoma or ocular hypertension. Includes ...
Cosopt
Cosopt reduces the amount of fluid in the eye and is used to treat glaucoma. Learn about side ...
Cosopt PF
Cosopt PF is used for glaucoma, open angle, intraocular hypertension
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.